"Glucose Intolerance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
| Descriptor ID |
D018149
|
| MeSH Number(s) |
C18.452.394.952.500
|
| Concept/Terms |
Glucose Intolerance- Glucose Intolerance
- Glucose Intolerances
- Intolerance, Glucose
- Intolerances, Glucose
- Impaired Glucose Tolerance
- Glucose Tolerance, Impaired
- Glucose Tolerances, Impaired
- Impaired Glucose Tolerances
- Tolerance, Impaired Glucose
- Tolerances, Impaired Glucose
|
Below are MeSH descriptors whose meaning is more general than "Glucose Intolerance".
Below are MeSH descriptors whose meaning is more specific than "Glucose Intolerance".
This graph shows the total number of publications written about "Glucose Intolerance" by people in this website by year, and whether "Glucose Intolerance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2021 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucose Intolerance" by people in Profiles.
-
Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies. Diabetologia. 2022 02; 65(2):275-285.
-
The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells. Diabetologia. 2021 06; 64(6):1358-1374.
-
Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability. Nat Commun. 2021 01 05; 12(1):24.
-
Pathophysiological Characteristics Underlying Different Glucose Response Curves: A Latent Class Trajectory Analysis From the Prospective EGIR-RISC Study. Diabetes Care. 2018 08; 41(8):1740-1748.
-
Sfrp5 associates with beta-cell function in humans. Eur J Clin Invest. 2016 Jun; 46(6):535-43.
-
Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study. Eur J Endocrinol. 2015 Apr; 172(4):423-32.
-
Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors. PLoS One. 2014; 9(11):e113154.
-
Sleep duration, lifestyle intervention, and incidence of type 2 diabetes in impaired glucose tolerance: The Finnish Diabetes Prevention Study. Diabetes Care. 2009 Nov; 32(11):1965-71.
-
Impaired glucose regulation and type 2 diabetes in children and adolescents. Diabetes Metab Res Rev. 2008 Sep; 24(6):427-37.
-
The genetic variation of the tenomodulin gene (TNMD) is associated with serum levels of systemic immune mediators--the Finnish Diabetes Prevention Study. Genet Med. 2008 Jul; 10(7):536-44.
MeSH information
